United Kingdom · 
Who invested in Vantia Therapeutics?
Vantia Therapeutics's investors include SV Life Sciences, Novo Holdings A/S and MVM Life Science Partners.
United Kingdom · Series B startup
Who invested in Vantia Therapeutics
One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$6.5Mraised across 1 round since 2011, from 1 source
- Latest round
- Series B, $6.5MJul 2011
- Investors
- 3
The rounds
- Jul 2011Series B$6.5M
Reported by vantiatherapeutics.com
Everyone who backed them
SV Life SciencesVC firm1round
Novo Holdings A/SGrowth equity1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Vantia Therapeutics
How much has Vantia Therapeutics raised?
Vantia Therapeutics has raised $6.5M across 1 round since 2011.
When did Vantia Therapeutics last raise?
Vantia Therapeutics's most recent round was a Series B of $6.5M in Jul 2011.
What was Vantia Therapeutics's biggest round?
Its most recent round, $6.5M in Jul 2011, is also its largest on record.
Who backed Vantia Therapeutics first?
Vantia Therapeutics's first round on record, in Jul 2011, was backed by SV Life Sciences, Novo Holdings A/S and MVM Life Science Partners.
What stage is Vantia Therapeutics at?
Vantia Therapeutics's latest named round is a Series B, in Jul 2011.
Where is Vantia Therapeutics based?
Vantia Therapeutics is based in the United Kingdom.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.